We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Dementia Biomarker Levels Fluctuate Throughout the Day

Brown wooden clocks with white faces showing different times.
Credit: Jon Tyson/ Unsplash
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Researchers found that the biomarkers used to diagnose Alzheimer's, including a promising marker for early diagnosis of the condition, varied significantly depending on the time of day. Biomarker levels were at their lowest in the morning when participants woke and highest in the evening. 


The p-tau217 biomarker, which could help with early diagnosis of dementia, showed big differences depending on the time of day. Researchers discovered that the variation between morning and evening levels was similar to the changes seen in people whose mild memory problems get worse over a year. 


"This work shows the importance of considering the time of day when taking clinical diagnostic samples and how the clinical picture for an individual may be affected by varying sample times. By standardising the time of day that a sample is taken, the diagnosis of dementia and tracking disease progression can become more accurate." - Dr Ciro della Monica, Research Fellow

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE
The study looked at 38 participants living with mild Alzheimer's, their caregivers and health controls while they were residents at the Surrey Sleep Research Centre, which is part of the UK Dementia Research Institute’s (UK DRI) Care Research & Technology Centre.


Instead of taking one blood sample, as is the case in the majority of clinical practices, the participants had their blood taken every three hours for 24 hours. 


Four out of five measured biomarkers (p-tau217, Aβ40, Aβ42, and NfL) showed levels of fluctuation throughout the day. Only GFAP did not show a statistically significant variation.


Currently, it is not known what is driving these time-of-day differences.  It may relate to sleep and sleep-related reduction in the production or clearance of these markers from the brain to the circulation, meals, posture, activity, or circadian mechanisms. Nevertheless, the findings imply that the time of day of sample collection is relevant in the implementation and interpretation of plasma biomarkers in dementia research and care. Overall, these findings indicate that the time of sampling should be standardised or at least recorded.


"Circadian rhythm research has demonstrated that almost all variables related to physiology and brain function vary with the time of day. This study shows that translating this basic knowledge to the area of dementia research holds great promise for a better understanding, diagnosis and treatment of Alzheimer's." -  Professor Derk-Jan Dijk, Professor of Sleep and Physiology, Director Surrey Sleep Research Centre


Reference: della Monica C, Revell V, Atzori G, et al. P-tau217 and other blood biomarkers of dementia: variation with time of day. Transl Psychiatry. 2024;14(1):1-9. doi:10.1038/s41398-024-03084-7


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.